Telomere Shortening
17
1
3
5
Key Insights
Highlights
Success Rate
63% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 72/100
17.6%
3 terminated out of 17 trials
62.5%
-24.0% vs benchmark
6%
1 trials in Phase 3/4
0%
0 of 5 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 5 completed trials
Clinical Trials (17)
TA-65 and Aging Associated Microvascular Dysfunction
Obesity and Aging: Impacts of Nutritional Counseling and Physical Exercise on Telomeres and Senescence Parameters
Study to Evaluate of EXG34217 in Patients With Telomere Biology Disorders With Bone Marrow Failure
The TELO-SCOPE Study: Attenuating Telomere Attrition With Danazol. Is There Scope to Dramatically Improve Health Outcomes for Adults and Children With Pulmonary Fibrosis
Lifestyle Change for Better Health
Effect of Infections and Global DNA Methylation on Frailty Trajectories in Hospitalized Older Patients (INFRAGEN)
Physical Exercise in Patients With Schizophrenia
Biological and Behavioral Outcomes of Community Nature Walks
Nandrolone Decanoate in the Treatment of Telomeropathies
Genetic Evaluation and Modification of Lifestyles to Improve Female Life Expectancy
Nasal Brushing for the Diagnosis and Understanding of Telomeropathies
CBART: The Reduction of Psychological and Physiological Stress in Women Undergoing IVF
Efficacy of Pythagorean Self-Awareness for Aging Biomarkers Improvement, in T2D Patients and Healthy Individuals.
Telomere Length in Relation to Acute Stress Response in Critical Care Patients
Evaluating Efficacy and Safety of Danazol in Severe Hematologic or Pulmonary Disease Related to Telomeropathy
Stress-Busting Program and QoL, Bio-markers of Immunity/Stress and Cellular Aging
Rosuvastatin Effect on Telomere-telomerase System in ACS